cjc 1295 muscle growth: Frequently asked questions

Check the compound's purity and storage conditions first. CJC-1295 is a fragile peptide. Temperature excursions above 8°C during shipping or storage can denature the protein structure, rendering it biologically inactive. Real Peptides ships all research peptides in temperature-controlled packaging with cold packs and provides third-party purity verification for every batch. If storage wasn't the issue, consider dosing frequency: some individuals are poor responders to GHRH analogs due to low baseline somatotroph receptor density. Increasing dose to 2 mg twice weekly or stacking with a ghrelin mimetic like ipamorelin (which triggers GH release through a different receptor pathway) often overcomes partial non-response.

You'll see minimal lean mass gains. CJC-1295 creates an anabolic environment by elevating IGF-1, but muscle hypertrophy requires mechanical tension. Progressive overload through resistance training. Without that stimulus, the elevated GH and IGF-1 improve recovery markers and may shift body composition slightly (modest fat loss, small increases in lean mass), but the magnitude is far below what's observed in trained subjects. Research comparing sedentary vs resistance-trained individuals on GHRH analogs consistently shows 2–3× greater lean mass accretion in the trained group.

These are GH-mediated side effects caused by fluid retention and soft tissue swelling. Common at doses above 2 mg per injection or in individuals with pre-existing carpal tunnel compression. Reduce the dose by 25–50% and assess symptom resolution over 7–10 days. GH's effect on extracellular fluid distribution is dose-dependent and reversible. If symptoms persist at lower doses, switch to Modified GRF 1-29 (CJC-1295 No DAC), which produces pulsatile GH spikes without the sustained elevation that drives fluid retention. The DAC modification is what extends half-life, but it's also what increases side effect incidence in sensitive individuals.

Verify your protein intake first. Most non-responders aren't consuming 1.6g/kg daily, and meal-by-meal leucine content often falls below the 2.5g threshold needed for maximal mTOR activation. Track total daily intake with a food scale for one week to confirm. If protein is adequate, evaluate training volume: are you hitting each muscle group with at least 10-20 working sets per week? Progressive overload. Adding weight, reps, or sets over time. Is non-negotiable. IGF-1 elevation amplifies the training signal, but if the signal itself is insufficient, no peptide will compensate. Finally, confirm peptide storage and reconstitution: lyophilised CJC-1295 must be stored at -20°C before mixing, and once reconstituted with bacteriostatic water, it must be refrigerated at 2-8°C and used within 28 days. Temperature excursions above 8°C denature the peptide structure irreversibly.

CJC-1295 increases appetite in some users, particularly when stacked with ghrelin receptor agonists like ipamorelin or MK-677. If you're gaining weight (scale increase) but body composition isn't improving (no visual muscle changes, waist circumference increasing), you're in a caloric surplus without adequate training stimulus. The peptide doesn't partition nutrients toward muscle preferentially. It raises the anabolic ceiling, but caloric excess still deposits as adipose tissue if training volume is low. Reduce caloric intake to maintenance or a slight surplus (200-300 kcal above TDEE), ensure protein remains at 1.6-2.0g/kg, and increase training frequency or volume. A DEXA scan or skinfold caliper measurement confirms whether lean mass is actually increasing or if the weight gain is primarily fat and water.

Muscle gained during CJC-1295 use is real contractile tissue, not temporary water or glycogen inflation, provided the gains occurred over 8-12 weeks with consistent training. When you stop the peptide, GH and IGF-1 levels return to baseline within 2-3 weeks, and the enhanced recovery capacity disappears. Muscle tissue itself doesn't vanish, but the rate of protein synthesis slows, and the training stimulus required to maintain that muscle increases. If you reduce training volume or protein intake after stopping, muscle loss is likely. Not because the peptide was 'holding' the muscle, but because maintenance requires continued stimulus. Plan a structured training program for post-cycle maintenance: keep volume high (at least 10 sets per muscle group weekly), maintain protein at 1.6g/kg minimum, and accept that further gains will be slower without the elevated IGF-1 environment.